Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cytlimic
company
About
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine.
- Higashi-shinagawa,Tokyo,Japan
- 1 - 10
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Dec 16, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Cytlimic Inc.
CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. CYTLIMIC’s products aim to activate immune systems to attack cancer cells while enabling patients to maintain a high quality-of-life during treatment.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥2.30B
Cytlimic has raised a total of
¥2.30B
in funding over 2 rounds. Their latest funding was raised on
Aug 9, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 9, 2019 | Series B | ¥1.30B | 3 | — | — | Detail |
| Dec 27, 2016 | Seed | — | 1 | — | — | Detail |
| Dec 19, 2016 | Series A | ¥1B | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Cytlimic is funded by 3 investors.
Fast Track Initiative, Inc.
and NEC Capital Solutions
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Fast Track Initiative, Inc.
|
— | Series B |
NEC Capital Solutions
|
— | Series B |
SMBC Venture Capital
|
— | Series B |
Employee Profiles
Number of Employee Profiles
7
Cytlimic has 7 current employee profiles, including
Board member Hiromichi Kimura
Board member
Board member
Executive
Executive
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
